MEETING ON THE MESA: Cartherics heads to California

By Karen Loudon / September 3, 2019
By Leigh Dayton, 2 September 2019 Cartherics has been invited to present at the prestigious Cell & Gene Meeting on...
Read More

Flow cytometry: The core characterisation technique for developing next-generation cancer immunotherapies

By Karen Loudon / August 28, 2019
CAR-T immunotherapy involves genetically engineering T-cells with chimeric antigen receptors (CARs). FLOW cytometry uses antibodies tagged with fluorescent markers that...
Read More

Monash University Student Open Day

By Karen Loudon / August 27, 2019
A student development evening was held again this year on 26 August 2019 at Monash University Clayton where Professor Graham...
Read More

Can an immune strategy used to treat cancer also wipe out HIV infections?

By Karen Loudon / August 12, 2019
Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That's why a small cadre...
Read More

Clinical Trials Bite Off Chunk of CAR T Therapy Market

By Karen Loudon / August 6, 2019
https://www.the-scientist.com/news-opinion/clinical-trials-bite-off-chunk-of-car-t-therapy-market-66212 About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead. Jul 30,...
Read More

CAR-T Cell Cancer Therapy to Save Lives (Media Release)

By Karen Loudon / August 5, 2019
https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/ The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients CAR-T Cell Therapy is...
Read More

Australian Actor Tom Long cancer-free after medical trial

By Karen Loudon / July 29, 2019
The Age, 28 July 2019 By Melissa Cunningham Former SeaChange actor Tom Long was on the brink of death when...
Read More

Cartherics’ research team just got bigger

By Karen Loudon / July 18, 2019
As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen.  That’s thanks...
Read More

Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

By Karen Loudon / July 3, 2019
STAT Biotech - By Sharon Begley @sxbegle JUNE 25, 2019 The U.S. patent office has declared an interference between a dozen...
Read More

Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting …….

By Karen Loudon / June 24, 2019
Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting with Cartherics Chairman Bob Moses and CEO Alan Trounson celebrating...
Read More

Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace

By Karen Loudon / June 7, 2019
Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been...
Read More

Science and Technology priorities – Election 2019

By Karen Loudon / May 8, 2019
MEDIA RELEASE 8 May 2019 Parties use science to set themselves apart .... The major parties have laid out their science...
Read More

The Next Frontier of CAR-T Cell Therapy: Solid Tumors

By Karen Loudon / April 4, 2019
The Technology has wowed the field by all but obliterating some patients' blood cancers, but sold malignancies present new challenges...
Read More

Miracle Elixirs

By Karen Loudon / April 4, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a...
Read More